FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 2023693 · Received March 18, 2011

Report

Report Number
1423500-2011-03368
Event Type
Injury
Date Received
March 18, 2011
Date of Event
October 1, 2010
Report Date
February 23, 2011
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
HR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICES INVOLVED IN THE INCIDENT WERE UNKNOWN. AS THE DATE OF ONSET OF THIS PERITONITIS EPISODE IS UNKNOWN AND PATIENTS DISCARD SUPPLIES AFTER EACH THERAPY, THE SAMPLE WAS NOT REQUESTED. A 510K NUMBER WILL NOT BE PROVIDED IN THE MDR AS THE PRODUCT CODE AND LOT NUMBER ARE UNKNOWN. SINCE THE LOT NUMBER IS UNKNOWN, NO BATCH REVIEW WILL BE PERFORMED. BAXTER HAS RECEIVED SIMILAR REPORTS FOR THE REPORTED PROBLEM. THE ROOT CAUSE INVESTIGATION IS IN PROGRESS.

Description of Event or Problem · 1

THIS IS A REPORT BY A PHYSICIAN FROM (B)(6) OF BREAK IN ASEPTIC TECHNIQUE, PYREXIA AND BACTERIAL PERITONITIS WITH CULTURE POSITIVE FOR E. COLI IN A PATIENT COINCIDENT WITH DIANEAL, UNKNOWN, AND EXTRANEAL VIAFLEX THERAPIES (LOT NUMBERS NOT REPORTED). ON (B)(6) 2010, THE PATIENT BEGAN TREATMENT WITH DIANEAL, UNKNOWN, AND EXTRANEAL VIAFLEX, (DOSES, FREQUENCIES AND LOT NUMBERS NOT REPORTED), INTRAPERITONEALLY (IP) FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD). ON AN UNREPORTED DATE, A BREAK IN ASEPTIC TECHNIQUE OCCURRED. ON (B)(6) 2010, THE PATIENT EXPERIENCED PYREXIA AND BACTERIAL PERITONITIS, MANIFESTED BY PYREXIA, ABDOMINAL PAIN AND CLOUDY EFFLUENT. FROM (B)(6) 2010 THROUGH (B)(6) 2010, THE PATIENT WAS TREATED WITH CEFUROXIME 1,5GM/DAY IP AND INTRAVENOUSLY (DUE TO ANTIBIOGRAM). ON AN UNREPORTED DATE, THE PATIENT RECOVERED FROM THE EVENT OF BACTERIAL PERITONITIS WITH CULTURE POSITIVE FOR E. COLI. THE OUTCOME FOR THE EVENT OF PYREXIA WAS NOT REPORTED AND IT WAS NOT REPORTED WHETHER THE PATIENT WAS RETRAINED IN ASEPTIC TECHNIQUE; THEREFORE, THE OUTCOME FOR THE EVENT OF BREAK IN ASEPTIC TECHNIQUE WAS UNKNOWN. THE SEVERITY OF THE PERITONITIS WAS CONSIDERED MILD BY THE REPORTER. HOSPITALIZATION AND ACTION TAKEN WITH DIANEAL AND EXTRANEAL WAS NOT REPORTED. CONCOMITANT MEDICATIONS WERE UNKNOWN. THE PHYSICIAN CONSIDERED THE EVENT OF BACTERIAL PERITONITIS WITH CULTURE POSITIVE FOR E. COLI UNRELATED TO DIANEAL AND EXTRANEAL; HOWEVER, DID NOT PROVIDE A STATEMENT OF CAUSALITY FOR PYREXIA AND BREAK IN ASEPTIC TECHNIQUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 60 YR Required Intervention DIANEAL| EXTRANEAL VIAFLEX